|
|||||
|
|
Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study |
|
| Authors: | Finn Richard S Bengala Carmelo Ibrahim Nuhad Roché Henri Sparano Joseph Strauss Lewis C Fairchild Justin Sy Oumar Goldstein Lori J |
| Affiliation: | Department of Medicine, Division of Hematology, Oncology, Geffen School of Medicine, UCLA Medical Center, Los Angeles, California 90095, USA. rfinn@mednet.ucla.edu |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |